Data Sheet

MSDS

Relugolix [CAS 737789-87-6]

CAS No:	737789-87-6
Applications:	Cancer-programmed cell death
MW:	623.63
Formula:	C₂₉H₂₇F₂N₇O₅S
SMILES:	O=C(NOC)NC1=CC=C(C(S2)=C(CN(C)C)C(C(N3C4=NN=C(OC)C=C4)=O)=C2N(CC5=C(F)C=CC=C5F)C3=O)C=C1
Purity:	99.67
Description:	Relugolix (TAK-385) is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209)[1]. Relugolix is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al[2].
Shipping Conditions:	Ship at ambient
Usage:	Research Use Only